Mystic Pharmaceuticals Receives US Patent For Novel Nose To Brain Delivery Of Therapeutics To Treat Neurodegenerative Disorders

Mystic Pharmaceuticals Receives US Patent For Novel Nose To Brain Delivery Of Therapeutics To Treat Neurodegenerative Disorders | Patexia